Cargando…
Dual-Targeted Therapy Circumvents Non-Genetic Drug Resistance to Targeted Therapy
The introduction of various targeted agents into the armamentarium of cancer treatment has revolutionized the standard care of patients with cancer. However, like conventional chemotherapy, drug resistance, either preexisting (primary or intrinsic resistance) or developed following treatment (second...
Autores principales: | Wang, Wei, Sun, Yue, Liu, Xiaobo, Kumar, Shaji K., Jin, Fengyan, Dai, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9093074/ https://www.ncbi.nlm.nih.gov/pubmed/35574302 http://dx.doi.org/10.3389/fonc.2022.859455 |
Ejemplares similares
-
The Strategies of Pathogen-Oriented Therapy on Circumventing Antimicrobial Resistance
por: Shang, Zifang, et al.
Publicado: (2020) -
From Therapy Resistance to Targeted Therapies in Prostate Cancer
por: Moreira-Silva, Filipa, et al.
Publicado: (2022) -
Targeting Oxidative Stress With Auranofin or Prima-1(Met) to Circumvent p53 or Bax/Bak Deficiency in Myeloma Cells
por: Tessoulin, Benoit, et al.
Publicado: (2019) -
Drug Resistance to Molecular Targeted Therapy and Its Consequences for Treatment Decisions in Non-Small-Cell Lung Cancer
por: Spaans, Johanna N., et al.
Publicado: (2014) -
Trials to Overcome Drug Resistance to EGFR and ALK Targeted Therapies – Past, Present, and Future
por: Spaans, Johanna N., et al.
Publicado: (2014)